Nanotechnology as a tool to overcome macromolecules delivery issues

Area of Science:

• Biotechnology
• Nanotechnology
• Drug Delivery

Background:

• Nanocarriers enhance drug targeting to specific organs or cells, improving therapeutic efficacy.
• Nanotechnology allows manipulation of material properties to address issues like poor drug solubility and bioavailability.
• Protein and macromolecule drugs often face challenges including short half-life, large size, and poor membrane permeability, limiting their effectiveness.

Purpose of the Study:

• To review biotech drug delivery approaches utilizing nanotechnology.
• To highlight the novelty of nanotechnology in overcoming drug delivery challenges.
• To discuss toxicological issues and regulatory considerations in nanomedicine.

Main Methods:

• Literature review of nanocarrier applications in biotech drug delivery.
• Analysis of nanotechnology's role in enhancing drug properties.
• Examination of challenges and regulations in nanomedicine development.

Main Results:

• Nanotechnology presents a promising strategy to improve the bioavailability and delivery of challenging biotech drugs.
• Selection of appropriate nanocarriers requires careful consideration of loading efficiency, physicochemical properties, and production.
• Toxicological concerns and regulatory pathways remain significant challenges for clinical application of nanomedicines.

Conclusions:

• Nanotechnology holds significant potential for advancing biotech drug delivery systems.
• Addressing toxicity and regulatory aspects is critical for the successful translation of nanomedicines from research to clinical practice.
• Further research and development are needed to optimize nanocarrier systems and navigate regulatory landscapes.